WASHINGTON D.C. — The U.S. Department of Justice and U.S. Drug Enforcement Administration have proposed reducing controlled substance manufacturing by between 7 and 15 percent in 2019 by adjusting the DEA’s the aggregate production quote, in the hopes of curbing opioid abuse by limiting the supply. In setting the aggregate production quote, DEA considers data from many…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.